Aclaris Therapeutics
在场
高管
查看带有其 19 名主要高管的组织结构图
Aclaris Therapeutics 搜索最多的简介
- Neal Walker, Interim Chief Executive Officer and Chairman of the B...
- Andrew Schiff, Director
- Andrew Powell, Director
高管在Aclaris Therapeutics变化
- Neal Walker 曾任 Chairman of the Board, 现升职为 Interim Chief Executive Officer and Chairman of the Board (新闻发布的2024一月17号).
- Douglas Manion, Director, President and Chief Executive Officer, 已经离开公司 (新闻发布的2024一月17号).
创建提醒
跟踪 Aclaris Therapeutics 的高管变动
药店
Aclaris Therapeutics 拥有 1,853 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- LakeShore Biopharma将在May 24, 2024将其名称改为LakeShore Biopharma。 (公布2024五月25号).
- MedMen has filed for bankruptcy protection (公布2024四月28号).
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
药店 行业的其他推荐联系人
消息
Aclaris Therapeutics 的最新新闻稿
- Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Provides R&D Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- View more press releases Close
通过电子邮件
